Education
About Us
Working with TipRanks
Follow Us
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.56M | $ 0.00 | $ 0.00 | $ 0.00 | $ 3.00M |
| Gross Profit | $ 1.76M | $ 0.00 | $ 0.00 | $ -1.89M | $ 3.00M |
| Operating Income | $ -36.40M | $ -107.52M | $ -87.57M | $ -85.11M | $ -59.87M |
| EBITDA | $ -27.58M | $ -94.89M | $ -89.33M | $ -84.54M | $ -58.06M |
| Net Income | $ -37.45M | $ -101.17M | $ -93.87M | $ -88.70M | $ -62.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 102.06M | $ 114.22M | $ 121.72M | $ 81.79M | $ 78.71M |
| Total Assets | $ 146.45M | $ 147.26M | $ 155.59M | $ 117.18M | $ 122.87M |
| Total Debt | $ 78.09M | $ 58.28M | $ 38.42M | $ 39.78M | $ 38.45M |
| Net Debt | $ 22.39M | $ -40.94M | $ -83.30M | $ -42.00M | $ -40.26M |
| Total Liabilities | $ 124.30M | $ 96.16M | $ 81.53M | $ 52.76M | $ 50.07M |
| Stockholders' Equity | $ 22.15M | $ 51.10M | $ 74.05M | $ 64.41M | $ 72.80M |
| Cash Flow | |||||
| Free Cash Flow | $ -131.23M | $ -96.57M | $ -77.20M | $ -71.52M | $ -60.18M |
| Operating Cash Flow | $ -130.90M | $ -96.51M | $ -77.10M | $ -70.91M | $ -58.82M |
| Investing Cash Flow | $ 66.99M | $ -14.88M | $ -103.00K | $ -615.00K | $ -1.36M |
| Financing Cash Flow | $ 20.29M | $ 88.52M | $ 117.23M | $ 74.25M | $ 12.39M |